DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
Illei GG, Shirota Y, Yarboro CH. et al.
Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.
Arthritis Rheum 2010;
62 (02) 542-552.
We do not assume any responsibility for the contents of the web pages of other providers.